For many, the medical and therapeutic potential of cannabis is what makes legalizing the marijuana plant such an important political and social task. Federal prohibition has established barriers to comprehensive cannabis research in the United States. However, researchers in other countries continue to make significant contributions to our knowledge of the cannabis plant and how it affects the human body.
Information on this website is provided for informational purposes only and is not intended as a substitute for the advice provided by your physician or other healthcare professional. You should not use the information on this website for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment. Any third party offering or advertising on this website does not constitute an endorsement by Andrew Weil, M.D. or Healthy Lifestyle Brands. 

Cannabis is known to aid relaxation, which makes it a popular treatment for social anxiety – however due to the THC content in cannabis, it can actually trigger more intense feelings of paranoia and anxiety. CBD on the other hand, has the opposite effect, helping to calm down the nerves and keep you grounded. Anxiety disorders and other feelings of irrational fear can be overwhelming especially if you find yourself in unfamiliar environments, however CBD can be used effectively to generate calmness and peacefulness, and without the addictive component of anti-anxiety medication like Benzos or Xanax.
If your intention is to help treat chronic pain, then you may want to start out with a lower dose, and then proceed from there. If you notice effective results, you can downsize the dose, or likewise you can always up the dose until positive results are achieved. The key is to only increase your dosage in small increments so that you are able to pinpoint exactly how much CBD oil it takes to treat your condition. Be advised, though, that you should not exceed the recommended daily doses that are listed on the bottle and you should consult with a physician.
Cannabis, (genus Cannabis), plant belonging to the family Cannabaceae of the nettle order (Urticales). By some classifications, the genus Cannabis comprises a single species, hemp (Cannabis sativa), a stout, aromatic, erect annual herb that originated in Central Asia and is now cultivated worldwide, including in Europe, southern Asia, the Middle East, India, Africa, and the Americas. A tall canelike variety is raised for the production of hemp fibre, while the female plant of a short branchier variety is prized as the more abundant source of the psychoactive substance tetrahydrocannabinol (THC), the active ingredient of marijuana.

Only a handful of countries have legalized recreational marijuana. Uruguay was one of the first, in 2013. The Netherlands is perhaps the country most known for legal marijuana, yet the drug is illegal there. Spain has given its citizens the rights to grow and consume cannabis privately. Peru also allows citizens to possess marijuana as long as it is for personal, private use. As in Costa Rica, where people can have a “small amount,” without legal trouble.
In 1976, Canadian botanist Ernest Small[66] and American taxonomist Arthur Cronquist published a taxonomic revision that recognizes a single species of Cannabis with two subspecies: C. sativa L. subsp. sativa, and C. sativa L. subsp. indica (Lam.) Small & Cronq.[62] The authors hypothesized that the two subspecies diverged primarily as a result of human selection; C. sativa subsp. sativa was presumably selected for traits that enhance fiber or seed production, whereas C. sativa subsp. indica was primarily selected for drug production. Within these two subspecies, Small and Cronquist described C. sativa L. subsp. sativa var. spontanea Vav. as a wild or escaped variety of low-intoxicant Cannabis, and C. sativa subsp. indica var. kafiristanica (Vav.) Small & Cronq. as a wild or escaped variety of the high-intoxicant type. This classification was based on several factors including interfertility, chromosome uniformity, chemotype, and numerical analysis of phenotypic characters.[52][62][67]
In 2014, the South Carolina legislature passed S 1035/H 4803, also known as “Julian’s Law.” The law creates an exemption for the possession and use of CBD from the criminal definition of marijuana in limited circumstances. Only patients with severe forms of seizure disorders are eligible for legal protections after the patient obtains a recommendation for CBD oil from a physician.
In the 1950s, the Narcotics Control Act and the Boggs Act stiffened penalties for marijuana possession, with first-time offenses requiring two to 10 year sentences and a minimum $20,000 fine, according to PBS.org. Penalties were relaxed in the 1970s, but President Ronald Reagan increased federal penalties for marijuana possession in the 1980s. On the federal level, marijuana is now regulated under the Controlled Substances Act as a schedule 1 drug, meaning the government considers it to have a high potential for abuse with no legitimate medical or therapeutic uses.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.
Sublingual CBD Oils – also known as CBD Tinctures or CBD Hemp Oil – are the most popular type of CBD products, because of their high bioavailability and rapid absorption. There are many other kinds of products as well, including CBD edibles, CBD topicals, and even CBD-infused Coffee. CBD products have gained immense popularity in health and wellness circles thanks to their natural support of our endocannabinoid system (ECS).
This product is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Individual weight loss results will vary. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law. All products contain less than 0.3% THC.
Cannabis was criminalized in various countries beginning in the 19th century. The British colonies of Mauritius banned cannabis in 1840 over concerns on its effect on Indian indentured workers;[205] the same occurred in British Singapore in 1870.[206] In the United States, the first restrictions on sale of cannabis came in 1906 (in District of Columbia).[207] It was outlawed in Jamaica (then a British colony) in 1913, in South Africa in 1922, and in the United Kingdom and New Zealand in the 1920s.[208] Canada criminalized cannabis in The Opium and Narcotic Drug Act, 1923,[209] before any reports of the use of the drug in Canada, but eventually legalized its consumption for recreational and medicinal purposes in 2018.[37]
^ Fusar-Poli, Paolo; Crippa, José A.; Bhattacharyya, Sagnik; Borgwardt, Stefan J.; Allen, Paul; Martin-Santos, Rocio; Seal, Marc; Surguladze, Simon A.; O'Carrol, Colin; Atakan, Zerrin; Zuardi, Antonio W.; McGuire, Philip K. (2009). "Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing". Archives of General Psychiatry. 66 (1): 95–105. doi:10.1001/archgenpsychiatry.2008.519. PMID 19124693.

There’s no definite amount that’s appropriate for everyone, but the ratio of CBD to THC will indicate how psychoactive the product is and if it’s legal in your state. The more CBD compared with THC, the less of a high, and vice versa. “Managing psychoactivity is key to successful cannabis therapy,” says Lee. “Amounts should be made clear on the label and lab-certified so people know what’s helping them and what’s not.”
The genus Cannabis was first classified using the "modern" system of taxonomic nomenclature by Carl Linnaeus in 1753, who devised the system still in use for the naming of species.[60] He considered the genus to be monotypic, having just a single species that he named Cannabis sativa L. (L. stands for Linnaeus, and indicates the authority who first named the species). Linnaeus was familiar with European hemp, which was widely cultivated at the time. In 1785, noted evolutionary biologist Jean-Baptiste de Lamarck published a description of a second species of Cannabis, which he named Cannabis indica Lam.[61] Lamarck based his description of the newly named species on plant specimens collected in India. He described C. indica as having poorer fiber quality than C. sativa, but greater utility as an inebriant. Additional Cannabis species were proposed in the 19th century, including strains from China and Vietnam (Indo-China) assigned the names Cannabis chinensis Delile, and Cannabis gigantea Delile ex Vilmorin.[62] However, many taxonomists found these putative species difficult to distinguish. In the early 20th century, the single-species concept was still widely accepted, except in the Soviet Union where Cannabis continued to be the subject of active taxonomic study. The name Cannabis indica was listed in various Pharmacopoeias, and was widely used to designate Cannabis suitable for the manufacture of medicinal preparations.[63]
Hemp oil is an oil extracted from the hemp plant. All plants in the Cannabis genus can produce the oil, but usually only industrial hemp is used to make hemp oil. Industrial hemp is a hemp varietal which has been cultivated specifically for industrial production, and it has a minimum of the psychoactive substances associated with the genus, most notably THC. Hemp oil is typically almost free of THC, and it has no psychoactive properties.
Cannabis use is associated with increased recruitment of task-related areas, such as the dorsolateral prefrontal cortex, which is thought to reflect compensatory activity due to reduced processing efficiency.[113][112][115] Cannabis use is also associated with downregulation of CB1 receptors. The magnitude of down regulation is associated with cumulative cannabis exposure, and is reversed after one month of abstinence.[116][117][118] There is limited evidence that chronic cannabis use can reduce levels of glutamate metabolites in the human brain.[119]
     2015 and beyond will bring many exciting changes to the current High CBD Hemp oil market. The Hemp plant once again being cultivated domestically for the first time in decades, will allow for companies producing Cannabidiol Rich Hemp products to source their base material from domestic suppliers, raising the bar on many of the current offerings that are using imported Hemp base from Europe from commercial strains that just happened to have decent CBD levels rather than strains actually developed to have high CBD levels, that are grown out seedlessly like traditional Marijuana for the strongest concentrations of Cannabindoids, such as those found within Marijuana oil.

Inhibited liver function: The liver regulates the way different drugs are metabolized within the body; this process is known as hepatic drug metabolism. Higher-than-average doses of CBD oil can slow the hepatic drug metabolism process. As a result, users may not be able to process other drugs as quickly. This is particularly concerning for CBD oil users who also take prescription medications.

Distinguishing cannabis and hemp can be confusing, so let's make it simple. There are many varietals of Cannabis sativa, all of which have different amounts of THC and CBD. Cannabis sativa varietals that have more than 0.3 percent THC are commonly referred to as marijuana. Hemp is any varietal of Cannabis sativa that contains less than 0.3 percent THC.
Cannabis is a generic term used to denote the several psychoactive preparations of the plant Cannabis sativa. The major psychoactive consituent in cannabis is ∆-9 tetrahydrocannabinol (THC). Compounds which are structurally similar to THC are referred to as cannabinoids. In addition, a number of recently identified compounds that differ structurally from cannabinoids nevertheless share many of their pharmacological properties. The Mexican term 'marijuana' is frequently used in referring to cannabis leaves or other crude plant material in many countries. The unpollinated female plants are called hashish. Cannabis oil (hashish oil) is a concentrate of cannabinoids obtained by solvent extraction of the crude plant material or of the resin.
There are approximately 60 unique cannabinoids in cannabis plants, which can be classified as hemp plants or marijuana plants (there’s a difference!). CBD is one of them and is the second-most prevalent cannabinoid found in the plant; THC is another. This distinction is absolutely critical to understand because THC is the cannabinoid responsible for the “high” produced by traditional marijuana; it’s where the negative connotations and associations generally begin. 

Cannabidiol is insoluble in water but soluble in organic solvents such as pentane. At room temperature, it is a colorless crystalline solid.[43] In strongly basic media and the presence of air, it is oxidized to a quinone.[44] Under acidic conditions it cyclizes to THC,[45] which also occurs during pyrolysis (smoking).[46] The synthesis of cannabidiol has been accomplished by several research groups.[47][48][49]
In response to the FDA’s historic decision, the Drug Enforcement Administration (DEA) announced in September 2018 that it had removed Epidiolex from Schedule I classification, a category reserved for dangerous drugs with no medical value. Henceforth, Epidiolex would be considered a Schedule V drug, the least dangerous designation under the Controlled Substances Act.

^ Blest-Hopley G, Giampietro V, Bhattacharyya S (May 2018). "Residual effects of cannabis use in adolescent and adult brains - A meta-analysis of fMRI studies". Neuroscience and Biobehavioral Reviews. 88: 26–41. doi:10.1016/j.neubiorev.2018.03.008. PMID 29535069. This may reflect the multitude of cognitive tasks employed by the various studies included in these meta-analyses, all of which involved performing a task thereby requiring the participant to reorient their attention and attempt to solve the problem at hand and suggest that greater engagement of this region indicates less efficient cognitive performance in cannabis users in general, irrespective of their age.
Hemp oil is an oil extracted from the hemp plant. All plants in the Cannabis genus can produce the oil, but usually only industrial hemp is used to make hemp oil. Industrial hemp is a hemp varietal which has been cultivated specifically for industrial production, and it has a minimum of the psychoactive substances associated with the genus, most notably THC. Hemp oil is typically almost free of THC, and it has no psychoactive properties.

CBD modulates/diminishes the effects of THC so is not a desired trait for recreational strains of cannabis for the most part, unless in very small concentrations. Strains that approach a 1:1 ratio of THC to CBD have little psychoactive effect and are more suitable for medicinal use where high THC doses can be uncomfortable for some. It is only with the recent surge of interest in Cannabidiol that breeders are getting the financial incentive to work with these previously abandoned hemp strains in order to bring CBD back into the Cannabis genetic pool and develope strains such as Charlotte's Web, Cannatonic, ACDC and Harlequin, among many other high CBD variants, some of which now have low enough THC levels to qualify for industrial Hemp status. A great breakdown of some of the most well known High CBD strains being used to make Marijuana oil and extracts in Medical Marijuana states today may be found here via Synergy Wellness's site.


^ Fusar-Poli, Paolo; Crippa, José A.; Bhattacharyya, Sagnik; Borgwardt, Stefan J.; Allen, Paul; Martin-Santos, Rocio; Seal, Marc; Surguladze, Simon A.; O'Carrol, Colin; Atakan, Zerrin; Zuardi, Antonio W.; McGuire, Philip K. (2009). "Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing". Archives of General Psychiatry. 66 (1): 95–105. doi:10.1001/archgenpsychiatry.2008.519. PMID 19124693.
There is a lot of excitement about hemp oil these days. There is also a lot of confusion. While many people have heard of hemp oil, they aren’t exactly sure what it does. Or whether or not it contains THC, the psychoactive ingredient in marijuana. Will hemp oil make you “high”? If you use a hemp oil supplement are you breaking any laws? The following are answers to some of the most frequently asked questions about hemp oil.
Furthermore, medical cannabis use is legal in many more places than recreational marijuana use. Current research, alongside patient and caregiver testimony, attests to the many medicinal applications of marijuana. From pain to serious neurological diseases, medical cannabis is emerging as a safe and viable alternative to many common prescription medications.
The study involved 9,000 people and analyzed the influence of marijuana on C-reactive protein (CRP) which is known to be a significant marker of inflammation often linked with an increased risk of heart disease. Researchers found that marijuana smokers (who had smoked in the previous 30 days) had lower levels of CRP than people who didn’t smoke marijuana.
Colorado's first and oldest medical cannabis law is a citizens’ initiative called Amendment 20 that amends the state constitution to authorize patients to possess and use medical cannabis and to be assisted by a caregiver. Colorado's second medical cannabis law, the Colorado Medical Marijuana Code (C.R.S. 12-43.3-101 et seq.), was enacted by the legislature in the summer of 2010 to establish a dual licensing mechanism that regulates medical cannabis business at both the state and local level.
I suffer from Fibromyalgia, spinal stenosis, osteoporosis, arthritis, and 66 yeas of wear and tear. I was overwhelmed by the endless varieties of hemp oil even after reading all the product info, so I chose to go with Amazon’s pick.this has a subtle mint flavor and within 2days, I was seeing a reduction in pain, better mood, and improvements in my brain fog. They have a loyal customer now. Even the headache I have had for 6 months since being put on Gabapentin is gone which means I no longer take Advil like tic tacs!
Cannabidiol, or CBD for short, is a natural phyto-cannabinoid (or plant-based chemical compound) found in cannabis plants, including hemp and marijuana. Unlike other cannabinoids — namely tetrahydrocannabinol, or THC — CBD does not produce any psychoactive effects, and will actually counteract these effects to a degree. CBD will induce feelings of sleepiness; for this reason, it can be an effective soporific for people who struggle to fall and/or remain asleep due to insomnia and other sleep disorders.

As a result of intensive selection in cultivation, Cannabis exhibits many sexual phenotypes that can be described in terms of the ratio of female to male flowers occurring in the individual, or typical in the cultivar.[28] Dioecious varieties are preferred for drug production, where the female flowers are used. Dioecious varieties are also preferred for textile fiber production, whereas monoecious varieties are preferred for pulp and paper production. It has been suggested that the presence of monoecy can be used to differentiate licit crops of monoecious hemp from illicit drug crops.[22] However, sativa strains often produce monoecious individuals, probably as a result of inbreeding.
^ Vanyukov MM, Tarter RE, Kirillova GP, Kirisci L, Reynolds MD, Kreek MJ, Conway KP, Maher BS, Iacono WG, Bierut L, Neale MC, Clark DB, Ridenour TA (June 2012). "Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective". Drug and Alcohol Dependence (Review). 123 Suppl 1: S3–17. doi:10.1016/j.drugalcdep.2011.12.018. PMC 3600369. PMID 22261179.

Of course, because legal marijuana is in such a confusing transitional period, even here there are potential exceptions. The U.S. Food and Drug Administration (FDA) approved Epidiolex, a treatment for a rare form of pediatric epilepsy that contains CBD. The DEA decided to classify this as a Schedule 5 drug, the scheduling that indicates the lowest potential for addiction and abuse.
"Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
Cannabis flavonoids in whole cannabis extracts may also contribute useful activity (McPartland and Russo 2001). Apigenin inhibits TNF-α (Gerritsen et al 1995), a mechanism germane to multiple sclerosis and rheumatoid arthritis. Cannflavin A, a flavone unique to cannabis, inhibits PGE-2 thirty times more potently than aspirin (Barrett et al 1986), but has not been subsequently investigated.
However, because no tools existed for quality control, it was impossible to prepare a standardized medicine, so patients often received a dose that was either too low, having no effect, or too high, resulting in serious side effects. Moreover, Cannabis extract was not water-soluble and therefore could not be injected (in contrast to, e.g., the opiates), whereas oral administration was found to be unreliable because of its slow and erratic absorption. Because of such drawbacks, the medicinal use of Cannabis increasingly disappeared in the beginning of the twentieth century, and in 1937 Cannabis was removed from the US pharmacopoeia, a move that was followed by most other Western countries.27 Isolation and structure elucidation of the first pure active substances from Cannabis was not achieved until the 1960s.29

CBD is a 5-HT1A receptor agonist, which may also contribute to an anxiolytic effect.[155] This likely means the high concentrations of CBD found in Cannabis indica mitigate the anxiogenic effect of THC significantly.[155] The cannabis industry claims that sativa strains provide a more stimulating psychoactive high while indica strains are more sedating with a body high.[156] However this is disputed by researchers.[157]

Sativex® (GW Pharmaceuticals) is an oromucosal whole cannabis-based spray combining a CB1 partial agonist (THC) with a cannabinoid system modulator (CBD), minor cannabinoids and terpenoids plus ethanol and propylene glycol excipients and peppermint flavoring (McPartland and Russo 2001; Russo and Guy 2006). It was approved by Health Canada in June 2005 for prescription for central neuropathic pain in multiple sclerosis, and in August 2007, it was additionally approved for treatment of cancer pain unresponsive to optimized opioid therapy. Sativex is a highly standardized pharmaceutical product derived from two Cannabis sativa chemovars following Good Agricultural Practice (GAP) (de Meijer 2004), yielding Tetranabinex® (predominantly-THC extract) and Nabidiolex® (predominantly-CBD extract) in a 1:1 ratio. Each 100 μL pump-action oromucosal Sativex spray actuation provides 2.7 mg of THC and 2.5 mg of CBD. Pharmacokinetic data are available, and indicate plasma half lives of 85 minutes for THC, 130 minutes for 11-hydroxy-THC and 100 minutes for CBD (Guy and Robson 2003). Sativex effects commence in 15–40 minutes, an interval that permits symptomatic dose titration. A very favorable adverse event profile has been observed in over 2500 patient years of exposure in over 2000 experimental subjects. Patients most often ascertain an individual stable dosage within 7–10 days that provides therapeutic relief without unwanted psychotropic effects (often in the range of 8–10 sprays per day). In all RCTs, Sativex was adjunctively added to optimal drug regimens in subjects with intractable symptoms, those often termed “untreatable.” Sativex is also available by named patient prescription in the UK and the Catalonia region of Spain. An Investigational New Drug (IND) application to study Sativex in advanced clinical trials in the USA was approved by the FDA in January 2006 in patients with intractable cancer pain.
While there are more unknowns than knowns at this point, Grant says he doesn’t discount all the anecdotal CBD reports. “You hear somebody say, ‘Hey, I gave this to myself and my kid and we feel a lot better,’ and we should never dismiss that kind of information,” he says. He points out that many modern medicines were discovered when researchers followed up on exactly this sort of human trial-and-error evidence. “But we still need to do the studies that confirm whether all the good things are true, and how much to give, and how to give it,” he says. “These are all questions that need to be answered.”
More recent studies have focused on the mechanisms behind the schizophrenia–cannabis interaction. Epstein and Kumra (2014) tested the effect of cannabis on executive control of attention and cognitive function by comparing scores on the Attention Network Test among people with early-onset schizophrenia (EOS) and cannabis use disorder, only EOS, only cannabis use disorder, and controls. They found that the first group in particular had less efficient executive control of attention compared with those who had only EOS. They also found a smaller right caudal anterior cingulate cortex in subjects with EOS and cannabis use disorder. However, it is presently unclear whether this means that the smaller cortex surface leads to deficits in self-regulation and heavy cannabis use or if the direction of causation is in the opposite direction. More recent studies have suggested gene–environment correlation between cannabis use and schizophrenia in that the increased risk of schizophrenia after heavy and consistent cannabis use may be moderated by a shared gene that may explain part of the association (Power et al., 2014).
In the 1970s, the taxonomic classification of Cannabis took on added significance in North America. Laws prohibiting Cannabis in the United States and Canada specifically named products of C. sativa as prohibited materials. Enterprising attorneys for the defense in a few drug busts argued that the seized Cannabis material may not have been C. sativa, and was therefore not prohibited by law. Attorneys on both sides recruited botanists to provide expert testimony. Among those testifying for the prosecution was Dr. Ernest Small, while Dr. Richard E. Schultes and others testified for the defense. The botanists engaged in heated debate (outside of court), and both camps impugned the other's integrity.[57][58] The defense attorneys were not often successful in winning their case, because the intent of the law was clear.[65]
In this report, researchers reviewed 16 previously published studies testing the use of various cannabis-based medicines in the treatment of chronic neuropathic pain and found some evidence that cannabis-based medicines may help with pain relief and reduce pain intensity, sleep difficulties, and psychological distress. Side effects included sleepiness, dizziness, mental confusion. The authors concluded that the potential harm of such medicines may outweigh their possible benefit, however, it should be noted that the studies used a variety of cannabis-based medicines (e.g. inhaled cannabis and sprays and oral tablets containing THC and/or CBD from plant sources or made synthetically), some of which are more likely to result in these side effects than products without THC.

Hemp Oil

×